Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about Could a cholesterol-lowering drug treat Parkinson's
In their quest to find new treatments that could slow, stop or reverse Parkinson's disease, a progressive neurological condition that affects movement and speech, researchers in Britain are set to investigate in humans the potential of a cholesterol-lowering drug in treating the disease.
- Read more about New therapy to quickly heal respiratory infections
A new therapy that helps in quick healing of colds, bronchitis and several forms of respiratory allergies was launched here on Saturday.
- Read more about Crispr' gene editing technique may treat inherited blindness
A new gene editing technique which was hailed as the breakthrough of 2015 by Science Magazine has been found effective in preventing retinal degeneration in a type of inherited blindness, a study says.
- Read more about Good bacteria may help prevent pneumonia
The presence of a harmless bacterium found in the nose and on the skin may negatively impact the growth of a pathogen that commonly causes middle ear infections in children and pneumonia in children and older adults, says a new study.
- Read more about Hormonal therapy may treat postnatal depression
Treatment with a hormone that plays an important role in labour and breast-feeding can improve behaviour of mothers suffering from postnatal depression, a common disorder affecting 10 to 20 percent of mothers, says a study.
11 January 2016

Report on National Symposium on NATURAL COSMETICS: Innovation & Trend

Somalwar’s Nikalas Mahila Mahavidyalaya, Nagpur in collaboration with Mahatma Gandhi Institute For Rural Industrialization, Wardha had organized National Symposium on Natural Cosmetics: Innovation & Trends on 5^th January 2016. It was inaugurated by lightening traditional lamp by Dr.P.G.Yeole, Pro Vice Chancellor, RTM Nagpur University, Dr.Prafull Kale, Director-MGIRI, Dr.Seema Somalwar-Principal, Nikalas Mahila Mahavidyalaya, Advocate Shri Madhukarrao Somalwar, President, Somalwar Education Society, Vinay Kumar Singh-General Manager, Mikasa Cosmetics Limited, Dr. Sheela Kulkarni-HOD, LAD College.
- Read more about LivaNova PLC Provides Update on FDA Warning Letter
LivaNova PLC received a Warning Letter dated December 29, 2015, from the United States Food and Drug Administration (“FDA”) alleging certain violations of FDA regulations applicable to medical device manufacturers at its Munich, Germany and Arvada, Colorado facilities.
- Read more about MiMedx Receives Certificate From FDA Allowing The Export Of MiMedx Allografts
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced that it has recently posted an updated "Certificate to Foreign Government" on its website that describes all of the MiMedx sheet form allografts and the Food and Drug Administration FDA's certification that the listed products are HCT/P's.
- Read more about NeuroMetrix Receive FDA 510(k) Clearance for upgraded version of Quell®
NeuroMetrix, Inc. announced that it received a 510(k) clearance (K152954) from the U.S. Food and Drug Administration (FDA) for an upgraded version of Quell, the company's over-the-counter, 100% drug free chronic pain relief wearable. Under this 510(k), the Quell device can be controlled directly via the Quell Relief smartphone app. This provides an unprecedented level of convenience and comfort when using Quell to treat chronic pain.
- Read more about Takeda and Enterome Enter Into Strategic Drug Discovery Collaboration
Takeda Pharmaceutical Company Ltd. and Enterome Bioscience SA (“Enterome”) announced they have entered into a strategic drug discovery collaboration to research and develop potential new therapeutics directed at microbiome targets thought to play crucial roles in gastrointestinal disorders, including inflammatory bowel diseases (e.g. ulcerative colitis) and motility disorders (e.g. irritable bowel syndrome).

[adsense:336x280:8701650588]